BPMC
Price
$127.90
Change
-$0.20 (-0.16%)
Updated
Jun 5 closing price
Capitalization
8.26B
54 days until earnings call
LYRA
Price
$25.23
Change
-$0.10 (-0.39%)
Updated
Jun 6, 11:19 AM (EDT)
Capitalization
32.99M
67 days until earnings call
Interact to see
Advertisement

BPMC vs LYRA

Header iconBPMC vs LYRA Comparison
Open Charts BPMC vs LYRABanner chart's image
Blueprint Medicines
Price$127.90
Change-$0.20 (-0.16%)
Volume$4.45M
Capitalization8.26B
Lyra Therapeutics
Price$25.23
Change-$0.10 (-0.39%)
Volume$100
Capitalization32.99M
BPMC vs LYRA Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. LYRA commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Buy and LYRA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BPMC: $127.92 vs. LYRA: $24.89)
Brand notoriety: BPMC and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 171% vs. LYRA: 110%
Market capitalization -- BPMC: $8.26B vs. LYRA: $32.99M
BPMC [@Biotechnology] is valued at $8.26B. LYRA’s [@Biotechnology] market capitalization is $32.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, BPMC is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 6 TA indicator(s) are bullish while LYRA’s TA Score has 7 bullish TA indicator(s).

  • BPMC’s TA Score: 6 bullish, 4 bearish.
  • LYRA’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а +24.12% price change this week, while LYRA (@Biotechnology) price change was +396.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.26B) has a higher market cap than LYRA($33M). LYRA YTD gains are higher at: 141.182 vs. BPMC (46.664). LYRA has higher annual earnings (EBITDA): -44.7M vs. BPMC (-66.42M). LYRA has less debt than BPMC: LYRA (34.4M) vs BPMC (467M). BPMC has higher revenues than LYRA: BPMC (562M) vs LYRA (1.19M).
BPMCLYRABPMC / LYRA
Capitalization8.26B33M25,033%
EBITDA-66.42M-44.7M149%
Gain YTD46.664141.18233%
P/E RatioN/AN/A-
Revenue562M1.19M47,426%
Total Cash576MN/A-
Total Debt467M34.4M1,358%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BPMCLYRA
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 22 days ago
73%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GXG29.790.10
+0.34%
Global X MSCI Colombia ETF
SMMU49.980.05
+0.11%
PIMCO Short Term Municipal Bond Actv ETF
QYLD16.48-0.05
-0.30%
Global X NASDAQ 100 Covered Call ETF
MCR6.32-0.02
-0.32%
MFS Charter Income Trust
PSFM29.52-0.10
-0.33%
Pacer Swan SOS Flex (April) ETF

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with LYRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-0.14%
LYRA - BPMC
44%
Loosely correlated
+9.07%
ORIC - BPMC
42%
Loosely correlated
+0.88%
INSM - BPMC
42%
Loosely correlated
-1.29%
ARQT - BPMC
42%
Loosely correlated
+1.81%
AXON - BPMC
41%
Loosely correlated
+1.08%
More